Multiplikator Forward P/S: Tenon Medical (TNON)
Slow adoption of implants by surgeons and insurance risks are constraining growth rates. This chart from the GURU.Markets terminal illustrates the expected revenue multiple, where the parameter has stabilized at 0.70. Alliances with clinics to implement the Catamaran system and the acquisition of patents are creating synergy. A steady cash flow from scheduled joint fixation procedures is strengthening the current financial health of Tenon Medical, Inc. (TNON).
Ringkesan rincian data analitis Tenon Medical, Inc. (TNON)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Tenon Medical, Inc.|TNON - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal tenonmed.com|TNON - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Tenon Medical, Inc.|TNON - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Tenon Medical|Rasio cepet tenonmed.com
- rincian asil keuangan lan kelipatan valuasi:
TNON - Penghasilan resik perusahaan|Bathi sing dikarepake Tenon Medical, Inc.|TNON - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Tenon Medical Inc|TNON - Pangali PEG|Pangali EV/EBITDA Tenon Medical, Inc|TNON - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Tenon Medical|TNON - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan tenonmed.com|TNON - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Tenon Medical, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:TNON (Tenon Medical, Inc)
Tenon Medical, Inc. (TNON) specialization in high-tech systems for treating sacroiliac joint pathologies creates a stable foundation within the orthopedic niche. By analyzing the forward P/S multiple, an investor assesses the ratio of current market capitalization to projected revenue, which allows for determining the extent of overpayment for future earnings and eliminates the risk of purchasing an overheated asset amid inflationary pressures.
Karo sapa Tenon Medical, Inc. saingan
Multiplikator Forward P/S BSX (bostonscientific.com)|EW: Kapitalisasi marang prakiraan pendapatan|ResMed - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Corporation|ZBH: Multiplikator Forward P/S|COO - Rasio kapitalisasi marang dodolan sing dikarepake|ALGN (Align Corp) - Multiplikator Forward P/S|Globus Medical Corp (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Holdings, Inc. ATEC|Multiplikator Forward P/S AORT (artivion.com)|Multiplikator Forward P/S Enovis Corp ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Inc) - Multiplikator forward rega marang pendapatan|IRADIMED CORPORATION - Rega forward marang dodolan|EMBC (Embecta Health) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tandem Diabetes Care Inc TNDM|Rasio rega marang prakiraan pendapatan AxoGen Inc (AXGN)|SI-BONE, Inc. (SIBN) - Prakiraan rega marang pendapatan|Orthofix Corp - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake bioventus.com (BVS)|OrthoPediatrics Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Treace Medical Concepts Inc TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed Medical)|Rasio rega marang prakiraan pendapatan rxsight.com|Multiplikator forward rega marang pendapatan ClearPoint Neuro, Inc. (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences, Inc. SGHT|OBIO: Kapitalisasi marang prakiraan pendapatan|ANIK: Multiplikator forward rega marang pendapatan|InspireMD, Inc. - Rasio rega marang pendapatan sing dikarepake|zhjmedical.com (ZJYL) - Rasio rega marang prakiraan pendapatan|VANI (Vivani Medical Inc) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan XTNT|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NeuroOne Medical Technologies NMTC|Multiplikator Forward P/S MODD|Multiplikator forward rega marang pendapatan myomo.com MYO|Rasio rega marang prakiraan pendapatan Envoy Medical Inc COCH|Vivos Therapeutics Inc. (VVOS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|envveno.com - Multiplikator Forward P/S|SINT (Sintx Technologies Inc) - Kapitalisasi marang prakiraan pendapatan|Lifeward Ltd. (LFWD) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Autonomix (AMIX)|Rasio rega marang prakiraan pendapatan INVO Fertility|Bone Biologics Corp. (BBLG) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S DYNT (dynatronics.com)|Rega forward marang dodolan FNA|INVO Bioscience - Multiplikator Forward P/S
